Signal active
Investment Firm
Overview
KBC Private Equity - the investment company of KBC Group - provides development capital and finances buy-outs to medium-sized companies in Belgium and in Central and Eastern Europe, KBC's home markets. Boasting an experienced team of 28 people, it has more than 60 active investments in portfolio with a market value in excess of EUR 400 million.
KBC Private Equity aims to become one of the leading private equity providers on KBC Group's home markets. As an active shareholder with a long-term perspective, KBC Private Equity is involved in taking strategic decisions and providing support to management teams.
Highlights
1935
Banking
10001+
25
8
9
Early Stage Venture, Late Stage Venture, Seed
Investment Bank
Location
Europe
Contact Information
Social
Profile Resume
KBC, established in 1935 and headquartered in Europe., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Music, Customer Service, Biotechnology, Life Science, CleanTech, Therapeutics, Clinical Trials, Financial Services, Venture Capital, Health Care. The organization boasts a portfolio of 26 investments, with an average round size of $35.4M and 9 successful exits. Their recent investments include Aristo Music Technology, Limburgse Reconversie Maatschappij, argenx, BioGeneration Ventures, Forbion Capital Partners. The highest investment round they participated in was $105.6B. Among their most notable exits are Aristo Music Technology and Limburgse Reconversie Maatschappij. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
25
0
8
9
Investments
25
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Dec 15, 2021 | Allegro Biotech | Biotechnology | 1.7M |
May 24, 2022 | Unbox | Web3 | 8.0M |
Mar 12, 2024 | MICLEDI Microdisplays | Semiconductor | 25.0M |
Mar 14, 2024 | ELIS | Service Industry | 435.3M |
Exits
9
Funding Timeline
25
0
0
Funding Rounds
25
KBC has raised 25 rounds. Their latest funding was raised on Mar 14, 2024 from a Post-IPO Debt - ELIS round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Dec 15, 2021 | Pre Seed Round - Allegro Biotech | - | 1.7M | - |
May 24, 2022 | Seed Round - Unbox | - | 8.0M | - |
Mar 12, 2024 | Series A - MICLEDI Microdisplays | - | 25.0M | - |
Mar 14, 2024 | Post-IPO Debt - ELIS | - | 435.3M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.